Published online Aug 26, 2021. doi: 10.4252/wjsc.v13.i8.1049
Peer-review started: February 27, 2021
First decision: April 20, 2021
Revised: May 10, 2021
Accepted: July 27, 2021
Article in press: July 27, 2021
Published online: August 26, 2021
Processing time: 173 Days and 12.8 Hours
Compared to other vertebrates, the regenerative capacity of appendages in mammals is very limited. Deer antlers are an exception and can fully regenerate annually in postnatal mammals. This process is initiated by the antler stem cells (AnSCs). AnSCs can be divided into three types: (1) Antlerogenic periosteum cells (for initial pedicle and first antler formation); (2) Pedicle periosteum cells (for annual antler regeneration); and (3) Reserve mesenchyme cells (RMCs) (for rapid antler growth). Previous studies have demonstrated that AnSCs express both classic mesenchymal stem cells (MSCs) and embryonic stem cells (ESCs), and are able to differentiate into multiple cell types in vitro. Thus, AnSCs were defined as MSCs, but with partial ESC attributes. Near-perfect generative wound healing can naturally occur in deer, and wound healing can be achieved by the direct injection of AnSCs or topical application of conditioned medium of AnSCs in rats. In addition, in rabbits, the use of both implants with AnSCs and cell-free preparations derived from AnSCs can stimulate osteogenesis and repair defects of bone. A more comprehensive understanding of AnSCs will lay the foundation for developing an effective clinical therapy for wound healing and bone repair.
Core Tip: With the development of regenerative medicine in recent years, stem cell-based strategies for wound healing and bone repair have received increasing attention. Deer are the only mammals that can fully regenerate a complex organ (antler) annually. In this paper, by reviewing current publications, we summarize the molecular characterizations, locations, and functions of antler stem cells (AnSCs) to deepen our understanding of the unique stem cell-based epimorphic process in mammals. We also describe the research progress and future directions of AnSCs-based/cell-free therapies for wound healing and bone repair, focusing on the use of antlerogenic periosteum cells, pedicle periosteum cells, reserve mesenchyme cells, and extracellular molecules derived from AnSCs.